Home

Schizophrenia

Read time: 3 min

Congress highlights

Videogames and Psychosis: Concerns versus Opportunities

The Schizophrenia International Research Society (SIRS) 2023 congress hosted academics and the...

Bipolar, Schizophrenia

Read time: 4 min

Satellite symposium

Expanding Therapeutic Options and Developing Novel Long-Acting Injectables in Schizophrenia

The 2023 Schizophrenia International Research Society (SIRS) symposium opened on May 11, 2023 with...

Read time: 3 min

Congress highlights

Glutamate and Oxidative Stress: A novel approach to pathophysiology in schizophrenia

It is well accepted that a combination of genetic and environmental factors is implicated in the...

Read time: 4 min

Congress highlights

Is it time to abandon the current schizophrenia construct?

When a room full of attendees of the recent European Congress of Psychiatry held in Paris were...

Read time: 3 min

Congress highlights

Neuropsychiatric risk trajectories after COVID-19

On May 5th, 2023, the World Health Organization (WHO) downgraded the COVID-19 pandemic as no longer...

Read time: 7 min

Congress highlights

Steps towards long-term maintenance treatment for psychiatric disorders

Around 21% of patients with schizophrenia achieve clinical recovery – a statistic that hasn...

Read time: 5 min

Congress highlights

Understanding patient recovery and the challenges with implementing therapeutic interventions

With countries in the OECD* spending around 9% of their GDP** on health systems,1 it is easy...

Medical education resource center

Lundbeck Institute Campus

The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Israel
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in the Israel click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country